SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 50% Gains Investing
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dale Baker who wrote (4391)4/15/1999 12:53:00 PM
From: JSBRead Replies (2) of 118717
 
I've been buying IMCL.

Hell of a product, it seems.
In phaseII, it killed 14 of 16
tumors and reduced the other 2,
as I recall.

Unlike ENMD, their stuff works
on humans, while ENMD seems to
work well on rats, but has not
been tested on people.

They just recently received FDA
approval for phaseIII testing on
a wider group. IMCL seems to
think that they can have their
product on the market in 18
months, since they are fast
tracked.

It's just amazing that ENMD keeps
trading higher when they haven't
used their product on people, yet.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News